Corvus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 May 24 | BuyUS$34,624 | William Jones | Individual | 20,000 | US$1.73 | |
06 May 24 | BuyUS$1,000,000 | Richard Miller | Individual | 577,634 | US$1.73 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 2,211,954 | 3.54% |
Institutions | 5,321,924 | 8.51% |
VC/PE Firms | 10,219,270 | 16.3% |
Hedge Funds | 12,122,632 | 19.4% |
General Public | 32,675,501 | 52.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,943,654 | US$37.8m | 0% | 0.55% | |||
6,133,758 | US$33.4m | 0.18% | 0.6% | |||
5,988,874 | US$32.6m | 0% | 0.08% | |||
3,275,616 | US$17.8m | 0% | 8.77% | |||
1,765,737 | US$9.6m | 18.5% | no data | |||
1,650,500 | US$9.0m | 10.5% | no data | |||
563,932 | US$3.1m | -11.5% | 0.01% | |||
562,024 | US$3.1m | 7.47% | no data | |||
460,140 | US$2.5m | 23.8% | no data | |||
400,000 | US$2.2m | 4.58% | 1.52% | |||
371,403 | US$2.0m | 34.9% | no data | |||
282,444 | US$1.5m | 0% | no data | |||
204,598 | US$1.1m | 779% | no data | |||
153,773 | US$836.5k | 15% | no data | |||
127,300 | US$692.5k | -43.3% | 0.01% | |||
120,303 | US$654.5k | 0% | no data | |||
113,400 | US$616.9k | -38.7% | no data | |||
83,222 | US$452.7k | -5.44% | no data | |||
82,990 | US$451.5k | 27.8% | no data | |||
74,559 | US$405.6k | 0% | no data | |||
63,773 | US$346.9k | 0% | 0.09% | |||
53,010 | US$288.4k | 0% | no data | |||
50,000 | US$272.0k | 0% | 1.08% | |||
49,959 | US$271.8k | 0% | 0.01% | |||
47,786 | US$259.9k | -53.4% | no data |